Estrogens binding to GPER induce ovarian cancer cell proliferation through activation of multiple downstream signals such as ERK (extracellular-signal-regulated kinase), PI3K (phosphoinositide 3-kinase), and EGFR (epidermal growth factor receptor) [207]. The gene discussed is EGFR; the disease is ovarian carcinoma.